Open AccessP468: MRD AS A BIOMARKER FOR RESPONSE TO DONOR LYMPHOCYTE INFUSION AFTER AL‐LOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
Author(s) -
Teich K.,
Stadler M.,
Gabdoulline R.,
Wienecke C.,
Heida B.,
Klement P.,
Büttner K.,
Venturini L.,
Wichmann M.,
Puppe W.,
SchultzeFlorey C.,
Beutel G.,
Eder M.,
Ganser A.,
Heuser M.,
Thol F.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000844760.73678.68
Subject(s) - medicine , myeloid leukemia , minimal residual disease , donor lymphocyte infusion , transplantation , oncology , hematopoietic stem cell transplantation , myeloid , leukemia , immunology , gastroenterology